Karine Ancolio

1.2k total citations
14 papers, 1.0k citations indexed

About

Karine Ancolio is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Karine Ancolio has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 11 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Karine Ancolio's work include Alzheimer's disease research and treatments (14 papers), Ubiquitin and proteasome pathways (5 papers) and Nuclear Receptors and Signaling (3 papers). Karine Ancolio is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), Ubiquitin and proteasome pathways (5 papers) and Nuclear Receptors and Signaling (3 papers). Karine Ancolio collaborates with scholars based in France, United States and Japan. Karine Ancolio's co-authors include Frédéric Checler, Cristine Alvès da Costa, Philippe Marambaud, Elvira Lopez‐Perez, Nathalie Chevallier, Mark P. Mattson, Hélène Barelli, Jean‐Marie Warter, K. Uéda and Cécile Dumanchin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Karine Ancolio

14 papers receiving 1.0k citations

Peers

Countries citing papers authored by Karine Ancolio

Since Specialization

Citations

This map shows the geographic impact of Karine Ancolio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Ancolio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Ancolio more than expected).

Fields of papers citing papers by Karine Ancolio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karine Ancolio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Ancolio. The network helps show where Karine Ancolio may publish in the future.

Co-authorship network of co-authors of Karine Ancolio

This figure shows the co-authorship network connecting the top 25 collaborators of Karine Ancolio. A scholar is included among the top collaborators of Karine Ancolio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Ancolio. Karine Ancolio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	The C-terminal Fragment of Presenilin 2 Triggers p53-mediated Staurosporine-induced Apoptosis, a Function Independent of the Presenilinase-derived N-terminal Counterpart 2003 ·Journal of Biological Chemistry ·Cristine Alvès da Costa, Mark P. Mattson, Karine Ancolio, Frédéric Checler	48
2	Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons 2002 ·Proceedings of the National Academy of Sciences ·Cristine Alvès da Costa, Erwan Paitel, Mark P. Mattson, Robert Amson, Adam Telerman, Karine Ancolio, Frédéric Checler	118
3	α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells 2000 ·Neuroscience Letters ·Karine Ancolio, Cristine Alvès da Costa, K. Uéda, Frédéric Checler	91
4	Wild-type but Not Parkinson's Disease-related Ala-53 → Thr Mutant α-Synuclein Protects Neuronal Cells from Apoptotic Stimuli 2000 ·Journal of Biological Chemistry ·Cristine Alvès da Costa, Karine Ancolio, Frédéric Checler	182
5	Role of the proteasome in Alzheimer’s disease 2000 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Frédéric Checler, Cristine Alvès da Costa, Karine Ancolio, Nathalie Chevallier, Elvira Lopez‐Perez, Philippe Marambaud	84
6	Effect of protein kinase A inhibitors on the production of Aβ40 and Aβ42 by human cells expressing normal and Alzheimer's disease‐linked mutated βAPP and presenilin 1 1999 ·British Journal of Pharmacology ·Philippe Marambaud, Karine Ancolio, Cristine Alvès da Costa, Frédéric Checler	19
7	Unusual phenotypic alteration of β amyloid precursor protein (βAPP) maturation by a new Val-715 → Met βAPP-770 mutation responsible for probable early-onset Alzheimer’s disease 1999 ·Proceedings of the National Academy of Sciences ·Karine Ancolio, Cécile Dumanchin, Hélène Barelli, Jean‐Marie Warter, Alexis Brice, Dominique Campion, Thierry Frébourg, Frédéric Checler	141
8	C-Terminal Maturation Fragments of Presenilin 1 and 2 Control Secretion of APPα and Aβ by Human Cells and Are Degraded by Proteasome 1999 ·Molecular Medicine ·Cristine Alvès da Costa, Karine Ancolio, Frédéric Checler	20
9	Alzheimer's Disease-Linked Mutation of Presenilin 2 (N141I-PS2) Drastically Lowers APPα Secretion: Control by the Proteasome 1998 ·Biochemical and Biophysical Research Communications ·Philippe Marambaud, Cristine Alvès da Costa, Karine Ancolio, Frédéric Checler	30
10	Proteasome Inhibitors Prevent the Degradation of Familial Alzheimer’s Disease-Linked Presenilin 1 and Potentiate Aβ42 Recovery from Human Cells 1998 ·Molecular Medicine ·Philippe Marambaud, Karine Ancolio, Elvira Lopez‐Perez, Frédéric Checler	37
11	Proteasome inhibitors prevent the degradation of familial Alzheimer's disease-linked presenilin 1 and potentiate A beta 42 recovery from human cells. 1998 ·PubMed ·Philippe Marambaud, Karine Ancolio, Elvira Lopez‐Perez, Frédéric Checler	54
12	Post-transcriptional Contribution of a cAMP-dependent Pathway to the Formation of α- and β/γ-Secretases-Derived Products of βAPP Maturation in Human Cells Expressing Wild-type and Swedish Mutated βAPP 1998 ·Molecular Medicine ·Philippe Marambaud, Nathalie Chevallier, Karine Ancolio, Frédéric Checler	30
13	Characterization of New Polyclonal Antibodies Specific for 40 and 42 Amino Acid-Long Amyloid β Peptides: Their Use to Examine the Cell Biology of Presenilins and the Immunohistochemistry of Sporadic Alzheimer’s Disease and Cerebral Amyloid Angiopathy Cases 1997 ·Molecular Medicine ·Hélène Barelli, (unknown), Jean Vizzavona, P. Delaère, Nathalie Chevallier, (unknown), Philippe Marambaud, Karine Ancolio, Joseph D. Buxbaum, Olga Khorkova, (unknown), Sudhir Sahasrabudhe, Jean Martínez, Jean‐Marie Warter, Michel Mohr, Frédéric Checler	126
14	α‐Secretase‐Derived Product of β‐Amyloid Precursor Protein Is Decreased by Presenilin 1 Mutations Linked to Familial Alzheimer's Disease 1997 ·Journal of Neurochemistry ·Karine Ancolio, Philippe Marambaud, Pascale Dauch, Frédéric Checler	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact